Genentech proved the efficacy of satralizumab in a rare autoimmune disease. The risk of attacks decreased by 68%, new lesions by 79%. Learn how the first targeted drug fills the niche of empirical therapy.
May 14, 2026 · Enterprise network simulation platform ( eNSP ) Pro, also known as eNSP or datacom device simulator, is a device simulator launched by Huawei Data Communication Product Line.